ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) Director Michael Swinford purchased 16,907 shares of the firm’s stock in a transaction dated Friday, November 22nd. The shares were bought at an average price of $1.83 per share, for a total transaction of $30,939.81. Following the completion of the transaction, the director now owns 43,418 shares of the company’s stock, valued at approximately $79,454.94. This trade represents a 63.77 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
Michael Swinford also recently made the following trade(s):
- On Monday, November 25th, Michael Swinford acquired 21,622 shares of ReWalk Robotics stock. The shares were purchased at an average cost of $2.03 per share, with a total value of $43,892.66.
- On Wednesday, November 20th, Michael Swinford purchased 16,471 shares of ReWalk Robotics stock. The stock was purchased at an average cost of $1.84 per share, with a total value of $30,306.64.
ReWalk Robotics Trading Up 1.9 %
Shares of ReWalk Robotics stock opened at $2.10 on Thursday. The business’s 50-day moving average price is $2.54 and its 200-day moving average price is $3.49. The firm has a market capitalization of $18.50 million, a PE ratio of -0.84 and a beta of 2.07. ReWalk Robotics Ltd. has a 12 month low of $1.70 and a 12 month high of $9.10.
Analyst Ratings Changes
Separately, HC Wainwright reissued a “buy” rating and issued a $13.00 target price on shares of ReWalk Robotics in a research note on Wednesday, November 13th.
Check Out Our Latest Stock Report on LFWD
Institutional Trading of ReWalk Robotics
A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics at the end of the most recent quarter. Hedge funds and other institutional investors own 26.76% of the company’s stock.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Stories
- Five stocks we like better than ReWalk Robotics
- How Can Investors Benefit From After-Hours Trading
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Calculate Inflation Rate
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.